Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High vs Low Dose SAP Block in Valve Surgery
NCT06205875Recruiting
- Sponsor
- Jessa Hospital
- Start
- Feb 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Jessa Hospital. Primary endpoint: Cumulative opioid consumption by patient-controlled intravenous analgesia (PCIA) at 24 hours. Started Feb 2024; status: recruiting.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06205875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06205875.